Table 2.
aHR (95% CI) | P Value | |
---|---|---|
CAC Consortium (n = 446) | ||
Age ≥55 y in men, ≥65 y in women | 3.30 (1.30-8.40) | 0.01 |
Woman | 1.64 (0.58-4.61) | 0.35 |
Non-White race | 2.01 (0.85-4.75) | 0.11 |
Current cigarette smoking | 0.61 (0.08-4.62) | 0.63 |
Family history of CHD | 0.55 (0.21-1.47) | 0.23 |
Obesity | 2.17 (0.58-8.09) | 0.25 |
Hypertension | 1.54 (0.66-3.59) | 0.32 |
LDL-C ≥130 mg/dLa | 1.03 (0.44-2.45) | 0.94 |
HDL-C, per SD higherb | 1.12 (0.73-1.72) | 0.61 |
Diabetes | 2.56 (0.69-9.55) | 0.16 |
MESA (n = 119) | ||
Age ≥55 y in men, ≥65 y in women | 2.33 (0.96-5.66) | 0.06 |
Woman | 0.32 (0.14-0.74) | 0.008 |
Race/ethnicity | ||
White | Ref | - |
Chinese | 0.47 (0.11-2.03) | 0.31 |
Black | 0.78 (0.41-1.49) | 0.45 |
Hispanic | 2.91 (0.96-8.80) | 0.06 |
Current cigarette smoking | 0.80 (0.27-2.39) | 0.68 |
Family history of CHD | 1.04 (0.54-2.02) | 0.90 |
Obesity | 0.56 (0.22-1.40) | 0.21 |
Hypertension | 1.46 (0.77-2.78) | 0.25 |
LDL-C ≥130 mg/dLa | 0.73 (0.33-1.63) | 0.44 |
HDL-C, per SD higherb | 0.80 (0.51-1.24) | 0.32 |
Diabetes | 2.56 (0.86-7.66) | 0.09 |
aHR = adjusted hazard ratio; other abbreviations as in Table 1.
Also includes all individuals on lipid-lowering therapy.
13 mg/dL in CAC Consortium, 14 mg/dL in MESA.